Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
FDA Approves UroGen's Zusduri As First Drug For Recurrent Bladder Cancer
Via Benzinga
Exposures Product Safety
Tickers URGN
UroGen Soars On Price Target Upgrade On Heels Of FDA Approval For Cancer Medicine: Retail Sees Stock Touching $20
Via Stocktwits
Exposures Product Safety
Tickers IWM IWO URGN
SalesPlastics.com Launches Global Platform for Polymer Resin Buyers and Industrial Manufacturers
Via Get News
Topics Supply Chain
Exposures Product Safety Supply Chain
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Jim Hunter to Board of Directors
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
FDA Expands Moderna's RSV Vaccine Use To At-Risk Adults Aged 18–59 Amid CDC Panel Shake-Up
Via Benzinga
Exposures Product Safety
Tickers GSK MRNA PFE
Moderna’s RSV Vaccine Gets FDA Nod For Younger At-Risk Adults: Retail Stays Guarded Amid RFK Jr’s Immunization Shake-Up
Via Stocktwits
Topics Government
Exposures COVID-19 Political Product Safety
Tickers MRNA
Mesoblast Gives Positive Update About Potential FDA Application For Heart Failure Therapy: Retail Sees ‘Inflection Point’
Via Stocktwits
Exposures Product Safety
Tickers APIE ASX:MSB IBBQ MESO
BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics to Present at H.C. Wainwright Neuro Perspectives Conference
Via Investor Brand Network
Exposures Product Safety
Tickers BMWYY NRXP
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage
Via Investor Brand Network
Exposures Product Safety
Tickers NRXP
Tonix Pharma Stock Plunges 20% Pre-market On Share Sale Announcement, But Retail’s Not Pessimistic
Via Stocktwits
Exposures Product Safety
Tickers BA ITOT TNXP VXF
Jamie Dimon Recalls First Palantir Meeting: 'Holy Christ, This Is Unbelievable—' JPMorgan Now Has 600 AI Use Cases, $2 Billion Annual Investment On AI
Via Benzinga
Topics Artificial Intelligence Product Recall
Exposures Artificial Intelligence Legal Product Safety
Tickers JPM PLTR
Indian Markets Open Flat As Traders Eye Expiry Moves: SEBI RAs Set Nifty Range At 25,000–25,250
Via Stocktwits
Topics Government World Trade
Exposures Political Product Safety Tariff
Wabi Baby Reinforces Commitment to Quality and Safety with FDA and EPA-Registered UVC Sanitizers Trusted by Hospitals and Retailers
Via Press Release Distribution Service
Exposures COVID-19 Product Safety
AllColorScreen.com Grows From a Basic Display-Testing Page to a Robust Web Toolkit
Via AB Newswire
Topics Hacking Product Recall
Exposures Information Security Legal Product Safety
AbbVie Stock Rises After FDA Approves Expanded Treatment Scope For Mavyret, But Retail Needs More To Cheer
Via Stocktwits
Exposures Product Safety
Tickers ABBV VOO VTI
Nuvation Bio's Ibtrozi For ROS1-Positive Lung Cancer Wins FDA Approval
Via Benzinga
Exposures Product Safety
Tickers NUVB
FDA Expands AbbVie's Mavyret Label To Include Pediatric Patients With Hepatitis C Infection
Via Benzinga
Exposures Product Safety
Tickers ABBV ENTA
Insmed's Pulmonary Hypertension Drug Data Exceeded Even Bullish Outlook, Analysts Boost Price Forecast
Via Benzinga
Exposures Product Safety
Tickers INSM
Intelligent Bio Rises On Partnership With Smartox To Expand US Market Presence: Retail Hopes The Stock To Hit $2.6
Via Stocktwits
Exposures Product Safety
Tickers INBS VXF
FDA Completes Inspection of Capricor Therapeutics Manufacturing Facility For Deramiocel Approval: Retail Sees ‘Unimaginable Potential’
Via Stocktwits
Exposures Product Safety
Tickers AAPL CAPR VTI XBI
Maxwell Targets $500B Cosmetics Market with Microbiome-Friendly Antiseptics
Via Newsfile
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property Product Safety
Kaplan Fox is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Via NewMediaWire
Exposures Product Safety
Tickers UNCY
Kaplan Fox is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers UNCY
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands U.S. Forensic Market Presence Through SMARTOX Partnership
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis Product Safety
Tickers INBS
Lantern Pharma Inc. (NASDAQ: LTRN) Is ‘One to Watch’
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers LTRN
Novavax’s Covid-Flu Combo, Standalone Flu Vaccines Demonstrate Robust Immune Response In Late-Stage Trial: Retail Says It’s ‘A Very Good Sign’
Via Stocktwits
Exposures COVID-19 Product Safety
Tickers IWM NVAX VTI
Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs
Via FinancialNewsMedia
Exposures Product Safety
Tickers ONCY TSX:ONC
EXCLUSIVE: Intelligent Bio Solutions Expands US Forensic Market Presence, Seeks FDA Clearance For Fingerprint Drug Testing
Via Benzinga
Exposures Product Safety
Tickers INBS
CRL Q1 Earnings Call: Regulatory Changes and Market Stabilization Shape Outlook
Via StockStory
Topics Animal Testing
Exposures Animal Testing Product Safety
Tickers CRL
Kaplan Fox Announces an Investigation Into Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers UNCY
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.